Prednisone Delayed Release Tablet, Delayed Release
Product Images NDC 74157-019

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Prednisone Delayed Release (NDC 74157-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ina Pharmaceutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1b (1mg Bottle)

This is a medication information sheet for prednisone delayed-release tablets, each containing 1 mg of prednisone, USP. The tablets should be swallowed whole and not crushed, divided, or chewed. It is recommended to refer to the package insert for full prescribing information. The storage temperature should be between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The tablets are manufactured for INA Pharmaceutics Inc in Fairmont, WV, USA and are a product of Spain. The NDC code for this medication is 74157-010-30.*

FDA Label Image

1c (1mg Carton)

This is information about prednisone delayed-release tablets in the dosage strength of 1 mg. The tablets are to be swallowed whole and should not be crushed, divided, or chewed. The storage instructions mention keeping the tablets at controlled room temperature between 15°C and 30°C. The text also includes details like the lot number, expiry date, and the prescription code for the medication.*

FDA Label Image

2b (2mg Bottle)

Each delayed-release tablet contains 2 mg of prednisone USP. Dosage and administration information can be found on the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). They should be swallowed whole and not crushed, divided, or chewed. Manufactured for INA Pharmaceutics Inc, Fairmont, WV 26554, a product of Spain. This product is meant for use until January 2025.*

FDA Label Image

2c (2mg Carton)

This is a description of Prednisone Delayed-release Tablets with each tablet containing 2mg of Prednisone, manufactured in Spain for a pharmaceutical company in Fairmont. The tablets are meant to be swallowed whole and not crushed, divided, or chewed. The text provides dosage and administration information, along with storage instructions at controlled room temperature. It includes company contact details, product code, and regulatory information.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

This text provides information on the prednisone plasma concentrations measured in ng/mL over time after administration of 5mg immediate-release and delayed-release tablets. The data includes the time points in hours and the corresponding plasma concentrations in the graph.*

FDA Label Image

Figure2 (Figure2)

This information shows the ACR20 responders (%) comparison between patients treated with Etanercept, Prednisone delayed-release tablets, and DMARD (N=231) versus those treated with Placebo and DMARD (N=119).*

FDA Label Image

Logo (Ina Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.